Expect continued selling pressure as delisting risk persists. Monitor for a reverse stock split or other capital markets action to regain compliance before the December deadline. If the stock fails to recover above $1.00, delisting could severely reduce trading liquidity and institutional interest.
Price Chart
Executive Summary
RenovoRx received a second 180-day extension from Nasdaq until December 28, 2026 to regain compliance with the $1.00 minimum bid price requirement, after failing to do so by the original deadline. The stock remains at risk of delisting if the bid price does not close at $1.00 or higher for 10 consecutive business days during the extension period.
Key Facts
- Nasdaq notified RenovoRx on July 1, 2026 of eligibility for a second 180-day compliance period ending December 28, 2026.
- The company failed to regain compliance with the minimum bid price requirement during the initial 180-day period that ended June 30, 2026.
- If the closing bid price is at least $1.00 for 10 consecutive business days during the second period, Nasdaq will confirm compliance; otherwise, delisting procedures will commence.
- The company may appeal a delisting determination to a Nasdaq Hearings Panel.
Financial Impact
Potential loss of Nasdaq listing and associated liquidity reduction; market cap currently $43M.
Risk Factors
- Failure to regain compliance by December 28, 2026 leads to Nasdaq delisting.
- Potential reverse stock split may dilute shareholder value if executed at an unfavorable ratio.
- Ongoing non-compliance may deter new investors and impair access to capital markets.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-031662 |
| Document: 0001493152-26-031662-index-headers.html | 0001493152-26-031662 |
| Document: 0001493152-26-031662-index.html | 0001493152-26-031662 |
| Document: 0001493152-26-031662.txt | 0001493152-26-031662 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $1.27 | awaiting T+60 | — | $1.31 (+3.15%) |
Jul 29, 2026 12w ago | Press Release | $0.8981 $1.27 | ▲ +41.41% | ▲ +36.68% | $1.31 (+45.86%) |
Jul 2, 2026 16w ago | 8-K | $0.9201 $1.68 | ▼ −82.59% | ▼ −79.58% | $1.31 (−42.38%) |
May 26, 2026 21w ago | Press Release | $0.9160 $1.32 | ▲ +43.56% | ▲ +40.83% | $1.31 (+43.01%) |
May 19, 2026 22w ago | Press Release | $0.8060 $1.26 | ▲ +56.33% | ▲ +50.04% | $1.31 (+62.53%) |
May 15, 2026 23w ago | 10-K/A | $0.7830 $1.12 | ▲ +43.04% | ▲ +38.19% | $1.31 (+67.31%) |
May 14, 2026 23w ago | 8-K | $0.8200 $1.15 | ▲ +40.24% | ▲ +35.73% | $1.31 (+59.76%) |
Apr 29, 2026 25w ago | Press Release | $0.8310 $0.8653 | ▲ +4.13% | ▲ +0.02% | $1.31 (+57.64%) |
Apr 28, 2026 26w ago | EFFECT | $0.8400 $0.8545 | ▲ +1.73% | ▼ −2.26% | $1.31 (+55.95%) |
Apr 16, 2026 27w ago | S-3 | $1.00 $0.8500 | ▼ −15.00% | ▼ −21.14% | $1.31 (+31.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers